Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 80Head and Neck Neoplasms 72Nasopharyngeal Carcinoma 61Prostatic Neoplasms 51Oropharyngeal Neoplasms 30Carcinoma, Non-Small-Cell Lung 27Rectal Neoplasms 23Carcinoma, Squamous Cell 23Breast Neoplasms 23Glioblastoma 22Uterine Cervical Neoplasms 18Carcinoma 18Neoplasm Metastasis 16Brain Neoplasms 16Nasopharyngeal Neoplasms 15Pancreatic Neoplasms 14Lung Neoplasms 13Gliosarcoma 13Glioma 13Esophageal Neoplasms 13Radiation Injuries 12Mouth Neoplasms 12Laryngeal Neoplasms 12Esophageal Squamous Cell Carcinoma 12Astrocytoma 12Tongue Neoplasms 11Hypopharyngeal Neoplasms 11Sarcoma 10Neoplasms 10Salivary Gland Neoplasms 8

Interventions

Transcriptome 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Paclitaxel 1Microarray Analysis 1Immunohistochemistry 1Gene Expression Profiling 1Carboplatin 1Blotting, Western 1Biopsy 13-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Serous Adenocarcinoma × Radiotherapy, Intensity-Modulated × Clear all
NCT02112552 2023-08-29

Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
4 enrolled 6 charts
Gynecologic

Endometrial Serous Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡